107 related articles for article (PubMed ID: 9640227)
1. Antitumour activity and schedule dependency of 8-chloroadenosine-3',5'-monophosphate (8-ClcAMP) against human tumour xenografts.
Langdon SP; Ritchie AA; Muir M; Dodds M; Howie AF; Leonard RC; Stockman PK; Miller WR
Eur J Cancer; 1998 Feb; 34(3):384-8. PubMed ID: 9640227
[TBL] [Abstract][Full Text] [Related]
2. High antitumour activity of ET743 against human tumour xenografts from melanoma, non-small-cell lung and ovarian cancer.
Hendriks HR; Fiebig HH; Giavazzi R; Langdon SP; Jimeno JM; Faircloth GT
Ann Oncol; 1999 Oct; 10(10):1233-40. PubMed ID: 10586342
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, metabolism and tumour disposition of 8-chloroadenosine 3',5'-monophosphate in breast cancer patients and xenograft bearing mice.
Cummings J; Langdon SP; Ritchie AA; Burns DJ; Mackay J; Stockman P; Leonard RC; Miller WR
Ann Oncol; 1996 Mar; 7(3):291-6. PubMed ID: 8740794
[TBL] [Abstract][Full Text] [Related]
4. BNP7787, a novel protector against platinum-related toxicities, does not affect the efficacy of cisplatin or carboplatin in human tumour xenografts.
Boven E; Verschraagen M; Hulscher TM; Erkelens CA; Hausheer FH; Pinedo HM; van der Vijgh WJ
Eur J Cancer; 2002 May; 38(8):1148-56. PubMed ID: 12008205
[TBL] [Abstract][Full Text] [Related]
5. Growth inhibition by 8-chloro cyclic AMP of human HT29 colorectal and ZR-75-1 breast carcinoma xenografts is associated with selective modulation of protein kinase A isoenzymes.
Ramage AD; Langdon SP; Ritchie AA; Burns DJ; Miller WR
Eur J Cancer; 1995 Jun; 31A(6):969-73. PubMed ID: 7646930
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine.
Cao S; McGuire JJ; Rustum YM
Clin Cancer Res; 1999 Jul; 5(7):1925-34. PubMed ID: 10430100
[TBL] [Abstract][Full Text] [Related]
7. Comparative antitumour activity of vinblastine-isoleucinate and related vinca alkaloids in human tumour xenografts.
Hendriks HR; Langdon S; Berger DP; Breistøl K; Fiebig HH; Fodstad O; Schwartsmann G
Eur J Cancer; 1992; 28A(4-5):767-73. PubMed ID: 1524896
[TBL] [Abstract][Full Text] [Related]
8. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion.
Bernacki RJ; Oberman EJ; Seweryniak KE; Atwood A; Bergeron RJ; Porter CW
Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054
[TBL] [Abstract][Full Text] [Related]
9. Biological and pharmacological characterisation of three models of human ovarian carcinoma established in nude mice: use of the CA125 tumour marker to predict antitumour activity.
Burbridge MF; Kraus-Berthier L; Naze M; Pierre A; Atassi G; Guilbaud N
Int J Oncol; 1999 Dec; 15(6):1155-62. PubMed ID: 10568822
[TBL] [Abstract][Full Text] [Related]
10. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
[TBL] [Abstract][Full Text] [Related]
11. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
12. A novel cyclic adenosine monophosphate analog induces hypercalcemia via production of 1,25-dihydroxyvitamin D in patients with solid tumors.
Saunders MP; Salisbury AJ; O'Byrne KJ; Long L; Whitehouse RM; Talbot DC; Mawer EB; Harris AL
J Clin Endocrinol Metab; 1997 Dec; 82(12):4044-8. PubMed ID: 9398710
[TBL] [Abstract][Full Text] [Related]
13. Schedule dependency of orally administered bis-acetato-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) in vivo.
McKeage MJ; Kelland LR; Boxall FE; Valenti MR; Jones M; Goddard PM; Gwynne J; Harrap KR
Cancer Res; 1994 Aug; 54(15):4118-22. PubMed ID: 8033145
[TBL] [Abstract][Full Text] [Related]
14. Tissue distribution, antitumour activity and in vivo apoptosis induction by MEN10755 in nude mice.
Gonzalez-Paz O; Polizzi D; De Cesare M; Zunino F; Bigioni M; Maggi CA; Manzini S; Pratesi G
Eur J Cancer; 2001 Feb; 37(3):431-7. PubMed ID: 11239767
[TBL] [Abstract][Full Text] [Related]
15. Combination of a CpG-oligodeoxynucleotide and a topoisomerase I inhibitor in the therapy of human tumour xenografts.
Balsari A; Tortoreto M; Besusso D; Petrangolini G; Sfondrini L; Maggi R; Ménard S; Pratesi G
Eur J Cancer; 2004 May; 40(8):1275-81. PubMed ID: 15110894
[TBL] [Abstract][Full Text] [Related]
16. Experimental antitumour activity of S 16020-2 in a panel of human tumours.
Kraus-Berthier L; Guilbaud N; Jan M; Saint-Dizier D; Rouillon MH; Burbridge MF; Pierré A; Atassi G
Eur J Cancer; 1997 Oct; 33(11):1881-7. PubMed ID: 9470851
[TBL] [Abstract][Full Text] [Related]
17. Antitumour activity of cis-diamminedichloroplatinum (II) against human tumour xenografts depends on its area under the curve in nude mice.
Kurihara N; Kubota T; Hoshiya Y; Otani Y; Watanabe M; Kumai K; Kitajima M
J Surg Oncol; 1996 Feb; 61(2):138-42. PubMed ID: 8606546
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and toxicity profile of oral topotecan in a panel of human tumour xenografts.
De Cesare M; Zunino F; Pace S; Pisano C; Pratesi G
Eur J Cancer; 2000 Aug; 36(12):1558-64. PubMed ID: 10930804
[TBL] [Abstract][Full Text] [Related]
19. Antitumour activity, toxicity and inhibition of thymidylate synthase of prolonged administration of 5-fluorouracil in mice.
Codacci-Pisanelli G; van der Wilt CL; Pinedo HM; Franchi F; Noordhuis P; Braakhuis BJ; van Laar JA; Peters GJ
Eur J Cancer; 1995; 31A(9):1517-25. PubMed ID: 7577082
[TBL] [Abstract][Full Text] [Related]
20. Comparison of paclitaxel and docetaxel activity on human ovarian carcinoma xenografts.
Nicoletti MI; Lucchini V; D'Incalci M; Giavazzi R
Eur J Cancer; 1994; 30A(5):691-6. PubMed ID: 7915909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
